Nabla Appoints New CEO to Drive Growth in AI Scribe Market
AI clinical documentation firm Nabla has appointed Brian Manning as its new chief executive officer, effective immediately. Manning replaces co-founder Alex LeBrun, who remains with the company as executive chairman and chief AI officer while also serving at AMI Labs. Manning brings experience from Bamboo Health and PatientPing, where he held leadership roles in revenue operations. Nabla is expanding its presence in a competitive market for AI scribes, which are increasingly adopted to reduce administrative burdens on healthcare providers. The company currently partners with over 190 organizations, including major health systems like CVS Health and UCLA Health. Nabla also secured $70 million in Series C funding last year. The shift reflects broader industry interest in AI solutions for healthcare operations as the sector seeks efficiency amid workforce challenges.
Topics: AI scribes healthcare leadership change